A brief overview of the book
Directory of Approved Biopharmaceutical Products# Provides a brief overview of each biopharmaceutical approved in the US and by centralized European drug approval system in the EU
# Outlines the properties of each drug in consistent monograph format
# Includes information from both regulatory agencies and pharmaceutical companies
# Indexes drugs both by brand name and by biological activity
Biopharmaceuticals, the term for genetically engineered therapeutic proteins, monoclonal antibodies, and nucleic acid-based products, have become an increasing part of the pharmaceutical armament. While this category of drugs accounts for approximately 25% of all new drugs coming to market, very few references exist that review these commercially available products. Until now, accessing data on the list of currently approved biopharmaceuticals has been laborious and patchy.
Directory of Approved Biopharmaceutical Products brings together key information on various aspects of these compounds, presenting a brief summary of each biopharmaceutical currently approved for medical use. Each summary includes the scientific and trade name, year and regions approved, approved indications, manufacturer, marketing right, method of manufacture, scientific overview, and therapeutic properties. Based on information gathered from regulatory agencies and pharmaceutical manufacturers, the book presents the most comprehensive data currently available in a single, convenient volume.
This comprehensive and consistent approach will save professionals in the pharmaceutical industry hours spent trawling the literature - and provides a singular resource for future reference.
Publication Date September 2004
Publisher CRC Press
Product Type Book
Pages 336
ISBN Number 0415263689
Product Code CRC007
